Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 30, Issue 4, 1997, Pages 992-996

  Böhm, Michael ^a   Deutsch, Hans J ^a   Hartmann, Dagmar ^a   La Rosée, Karl ^a   Stäblein, Alexander ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; METOPROLOL; MILRINONE; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE TOLERANCE; FEMALE; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART RATE; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; DRUG SYNERGISM; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEART FAILURE, CONGESTIVE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MILRINONE; MYOCARDIAL CONTRACTION; PHOSPHODIESTERASE INHIBITORS; PYRIDONES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, CYCLIC AMP; STROKE VOLUME;

EID: 0342437444     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00248-9     Document Type: Article

References (32)

1. 2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991;43: 203-42.
2. Böhm M. Alterations of β-adrenoceptor G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem 1995;147:147-60.
3. Bristow MR, Anderson FL, Port DP, et al. Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991;84:1024-39.
4. Böhm M, Morano I, Pieske B, et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 1991;68:689-701.
5. Feldman MD, Copelas L, Gwathmey JK, et al. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75:331-9.
6. Böhm M, Gierschik P, Jakobs KH, et al. Increase of Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 1990;82:1249-65.
7. Feldman AM, Cates AE, Veazey WB, et al. Increase in the 40,000-mol wt pertussis toxin substrate (G-protein) in the failing human heart. J Clin Invest 1988;82:189-97.
8. Neumann J, Scholz H, Döring V, Schmitz W, von Meyerinck L, Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet 1988;2:936-7.
9. Reithmann C, Gierschik P, Sidiropoulos D, Werdan K, Jakobs KH. Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein α-subunits. Eur J Pharmacol 1989;172:211-21.
10. Eschenhagen T, Mende U, Diederich M, et al. Long-term β-adrenoceptor-mediated up-regulation of Giα and Goα mRNA levels and pertussis toxin sensitive guanine nucleotide binding proteins in rat heart. Mol Pharmacol 1992;42:773-83.
11. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994;90:1765-73.
12. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarson A. Long-term β-blockade in dilated cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989;80:551-63.
13. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
14. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334: 1348-55.
15. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989;79:483-90.
16. Gilbert EM, Olsen SL, Renlund DG, Bristow MR. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol 1993;71:23C-9C.
17. Sahn DJ, Demaria A, Kisslo J, Weymann A. Recommendations regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation 1978;58:1072-83.
18. von Scheidt W, Böhm M, Schneider B, Reichart B, Erdmann E, Autenrieth G. Isolated presynaptic inotropic β-adrenergic supersensitivity of the transplanted denervated human heart in vivo. Circulation 1992;85:1056-63.
19. von Scheidt W, Böhm M, Schneider B, Autenrieth G, Erdmann E. Cholinergic baroreflex vasodilatation: defect in heart transplant recipients due to denervation of the ventricular baroreceptor. Am J Cardiol 1992;69:247-52.
20. Crawford MH, Grant D, O'Rourke RA, Starling MR, Groves BM. Accuracy and reproducibility of new M-mode echocardiographic recommendations for measuring left ventricular dimensions. Circulation 1980;61:137-43.
21. Clark RD, Korcuska K, Cohn K. Serial echocardiographic evaluation of left ventricular function in valvular disease, including reproducibility guidelines for serial studies. Circulation 1980;62:564-75.
22. 1-adrenergic receptors in the failing human heart. Circulation 1993;87:454-63.
23. Parker JD, Landzberg JS, Bittl JA, Mirsky I, Colucci WS. Effects of β-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle. Circulation 1991;84:1040-8.
24. 2 in human end-stage heart failure. Circ Res 1992;70:688-96.
25. Brown LA, Harding SE. The effect of pertussis toxin on β-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure. Br J Pharmacol 1992;106:115-22.
26. Danielsen W, v. der Leyen H, Meyer W, et al. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharmacol 1989;14:171-3.
27. Böhm M, Diet F, Kemkes B, Erdmann E. Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heart. Klin Wochenschr 1988;66: 957-62.
28. Schnabel P, Böhm M, Gierschik P, Jakobs KH, Erdmann E. Improvement of cholera toxin-catalyzed ADP-ribosylation by endogenous ADP-ribosylation factor from bovine brain provides evidence for an unchanged amount of Gsα in failing human myocardium. J Mol Cell Cardiol 1990;22:73-82.
29. Müller FU, Boheler KR, Eschenhagen T, Schmitz W, Scholz H. Isoprenaline stimulates gene transcription of the inhibitory G protein alpha-subunit Gi alpha-2 in rat heart. Circ Res 1993;72:696-700.
30. Sigmund M, Jakob H, Becker H, et al. Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure. Eur J Clin Pharmacol 1996;51:127-32.
31. Woodley SL, Gilbert EM, Anderson JL, et al. β-Blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991;84:2426-41.
32. Packer M, Carver JR, Rodeheffer J, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-75.